Ligand validation:8X4I

MTA: 5'-DEOXY-5'-METHYLTHIOADENOSINE

MTA is a Ligand Of Interest in 8X4I designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8X4I_MTA_A_301	39%	63%	0.217	0.924	0.61	0.8	-	1	2	0	100%	1
8X41_MTA_A_301	79%	28%	0.126	0.973	1.73	1.16	2	1	0	0	100%	1
8X44_MTA_B_301	67%	49%	0.143	0.95	0.74	1.21	-	2	1	0	100%	1
8X45_MTA_B_301	54%	53%	0.164	0.929	0.71	1.08	-	1	0	0	100%	1
8X4O_MTA_B_301	53%	63%	0.174	0.936	0.58	0.82	-	1	3	0	100%	1
3C6K_MTA_B_401	100%	21%	0.022	0.994	1.17	2.08	2	8	0	0	100%	1
7XII_MTA_A_301	100%	21%	0.037	0.982	1.4	1.88	3	6	2	0	100%	1
8P1W_MTA_AAA_401	100%	64%	0.043	0.987	0.62	0.76	-	1	5	0	100%	1
9JRZ_MTA_A_303	100%	46%	0.043	0.983	0.77	1.31	-	2	2	0	100%	1
8RYE_MTA_A_301	99%	66%	0.043	0.982	0.59	0.7	-	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.